In contrast, we observed neither any noticeable apoptotic or inflammatory features, nor liver functional damage in the NAFLD phenotypic status resulting from hepatic Xbp1 ablation. Here, XBP1 is linked to metabolic dysfunction-associated steatotic liver disease.